DIMA Biotechnology LLC's Anti-DLL3(Rovalpituzumab biosimilar) mAb is a Human monoclonal antibody. The Anti-DLL3(Rovalpituzumab biosimilar) mAb Antibody was generated using DLL3 as the antigen. It reacts with Homo Sapiens, and Human. This antibody has been shown to work in applications such as: EIA, Immunoassay, ELISA, and Flow Cytometry.
Description
Anti-DLL3(Rovalpituzumab biosimilar) mAb